GLP-1 drugs were originally used to treat diabetes, but are now a popular method of weight loss, even as the drugs face concerns over affordability, insurance coverage and potential side effects, as Newsday has previously reported
Dosage and Frequency Once a week subqutaneous (Sub-q) Injection, administered in the fatty abdominal area or thigh
The Three Primary Injection Sites Clinical trials for branded medications like Mounjaro and Zepboundwhich contain the active ingredient tirzepatidehave identified three primary areas for subcutaneous administration
3, 4, or 5 meals a day the 5-meal layout adds two snacks, common when appetite is small on a GLP-1
Because the N-terminus of GLP-1 is critical to its biological function, we engineered the fusion proteins to leave the N-terminus of GLP-1 free
A prescription label or copy of your prescription